These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 20826430
1. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R. Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430 [Abstract] [Full Text] [Related]
2. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. De Santi L, Annunziata P, Sessa E, Bramanti P. J Neurol Sci; 2009 Dec 15; 287(1-2):17-26. PubMed ID: 19758606 [Abstract] [Full Text] [Related]
3. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation. Hesske L, Vincenzetti C, Heikenwalder M, Prinz M, Reith W, Fontana A, Suter T. Brain; 2010 Jun 15; 133(Pt 6):1637-54. PubMed ID: 20424288 [Abstract] [Full Text] [Related]
4. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis. Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, Kuerten S. Clin Immunol; 2010 Nov 15; 137(2):181-9. PubMed ID: 20797911 [Abstract] [Full Text] [Related]
5. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D. Arch Neurol; 2008 Jun 15; 65(6):753-61. PubMed ID: 18541795 [Abstract] [Full Text] [Related]
6. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF. Neuroimmunomodulation; 2008 Jun 15; 15(1):76-83. PubMed ID: 18667803 [Abstract] [Full Text] [Related]
7. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Shriver LP, Dittel BN. Am J Pathol; 2006 Sep 15; 169(3):999-1011. PubMed ID: 16936273 [Abstract] [Full Text] [Related]
8. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ. Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L. Brain; 2012 May 15; 135(Pt 5):1586-605. PubMed ID: 22447120 [Abstract] [Full Text] [Related]
9. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, Gini B, Bach SD, Martinello M, Bifari F, Galiè M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B. Stem Cells; 2009 Oct 15; 27(10):2624-35. PubMed ID: 19676124 [Abstract] [Full Text] [Related]
10. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Lab Invest; 1997 Mar 15; 76(3):355-64. PubMed ID: 9121118 [Abstract] [Full Text] [Related]
11. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Herrero-Herranz E, Pardo LA, Gold R, Linker RA. Neurobiol Dis; 2008 May 15; 30(2):162-73. PubMed ID: 18342527 [Abstract] [Full Text] [Related]
12. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Berard JL, Wolak K, Fournier S, David S. Glia; 2010 Mar 15; 58(4):434-45. PubMed ID: 19780195 [Abstract] [Full Text] [Related]
13. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Linker RA, Rott E, Hofstetter HH, Hanke T, Toyka KV, Gold R. Neurobiol Dis; 2005 Mar 15; 19(1-2):218-28. PubMed ID: 15837577 [Abstract] [Full Text] [Related]
14. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Huizinga R, Gerritsen W, Heijmans N, Amor S. Neurobiol Dis; 2008 Dec 15; 32(3):461-70. PubMed ID: 18804534 [Abstract] [Full Text] [Related]
15. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Aharoni R, Kayhan B, Eilam R, Sela M, Arnon R. Proc Natl Acad Sci U S A; 2003 Nov 25; 100(24):14157-62. PubMed ID: 14614135 [Abstract] [Full Text] [Related]
16. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses. Papadopoulos D, Rundle J, Patel R, Marshall I, Stretton J, Eaton R, Richardson JC, Gonzalez MI, Philpott KL, Reynolds R. J Neurosci Res; 2010 Feb 01; 88(2):346-59. PubMed ID: 19658199 [Abstract] [Full Text] [Related]
17. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role. Liblau R. J Neurol Sci; 2009 Dec 01; 287 Suppl 1():S17-23. PubMed ID: 20106343 [Abstract] [Full Text] [Related]
18. Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Kuhlmann T, Remington L, Cognet I, Bourbonniere L, Zehntner S, Guilhot F, Herman A, Guay-Giroux A, Antel JP, Owens T, Gauchat JF. Am J Pathol; 2006 Aug 01; 169(2):584-98. PubMed ID: 16877358 [Abstract] [Full Text] [Related]
19. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice. Lev N, Barhum Y, Melamed E, Offen D. Neurosci Lett; 2004 Apr 15; 359(3):139-42. PubMed ID: 15050683 [Abstract] [Full Text] [Related]
20. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. Nat Med; 2002 Jun 15; 8(6):620-4. PubMed ID: 12042814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]